Keynote Presentation

Breaking the Ceiling of IBD Therapies

Jean-Frédéric Colombel, MD

Professor of Medicine
Director of the Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center and the Leona M. and Harry B. Helmsley Charitable Inflammatory Bowel Disease Research Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Friday, January 21, 2022
8:10-8:40 a.m. EST

Increased knowledge of the pathogenesis of IBD has triggered a burst in development of several biological agents and small-molecule therapies in the last two decades. Although the increase in therapeutic options is positive, remission rates of patients with IBD given new therapeutic agents are plateauing and the long-term risk of complications and surgeries remains high at a population-based level. The question is thus: how can we break this so-called therapeutic ceiling?

About Dr. Colombel

Jean-Frédéric Colombel has been the director of the Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center since January 2013. Professor Colombel began his career at CHU de Lille, France in 1980 where he was Professor of Hepato-Gastroenterology from 1991, and Head of the Department of Gastroenterology from 2010 to 2012. Since 1984, his research has focused on IBD. Thanks to the development of multiple local, national and international collaborations, he has been able to contribute to important advances in the pathophysiology of IBD. Professor Colombel has trained several generations of fellows both in the US and in Europe, and many of them are now key opinion leaders in IBD in their respective countries. This leadership in IBD has been recognized and he was elected as the President of the European Crohn’s and Colitis Organisation (ECCO) (2008–2010) and Chair of the International Organization for the Study of Inflammatory Bowel Disease (IOIBD) (2010–2012). Professor Colombel was awarded the United European Gastroenterology Federation (UEGF) Research Prize in 2009 and the Crohn’s & Colitis Foundation Clinical Research Award in 2014 and the Sherman Prize in 2018. The main concretisation of Professor Colombel’s work has been the publication as primary author or co-author of more than 1000 peer-reviewed papers, most of them in the domain of IBD. Professor Colombel has been an associate editor of major gastroenterology journals including Gut, Alimentary Pharmacology and Therapeutics and Gastroenterology (current).

This presentation is supported by a generous grant from the Leona M. and Harry B. Helmsley Charitable Trust.

This website uses cookies to provide you with the best experience on our website. If you wish to disable cookies, please do so in your browser settings. Your continued use of our site without disabling your cookies is subject to the cookie policy. Learn More